Depression and Cognitive Impairment in Parkinson's Disease: A Role for Inflammation and Immunomodulation?

Publisher： Karger

E-ISSN： 1423-0216|21|2-3|88-94

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.21, Iss.2-3, 2014-02, pp. : 88-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Aminothiol Compounds, but Not Serum Tumor Necrosis Factor Receptor II and Soluble Receptor for Advanced Glycation End Products, Are Related to the Cognitive Impairment in Alzheimer’s Disease and Mild Cognitive Impairment Patients

By  

Neuroimmunomodulation, Vol. 14, Iss. 3-4, 2007-12 ,pp. : 163-167

Karger

Access to resources Recommend Favorite

FOXL2 Impairment in Human Disease

By  

Hormone Research in Paediatrics, Vol. 77, Iss. 1, 2012-01 ,pp. : 2-11

Karger

Access to resources Recommend Favorite

Serum Levels of Chemokines in Parkinson’s Disease

By  

Neuroimmunomodulation, Vol. 18, Iss. 4, 2011-03 ,pp. : 240-244

Karger

Access to resources Recommend Favorite

Postnatal Systemic Inflammation Exacerbates Impairment of Hippocampal Synaptic Plasticity in an Animal Seizure Model

By  

Neuroimmunomodulation, Vol. 20, Iss. 4, 2013-05 ,pp. : 223-232

Karger

Access to resources Recommend Favorite

Influence of Age and Gender on Cytokine Expression in a Murine Model of Parkinson’s Disease

By  

Neuroimmunomodulation, Vol. 14, Iss. 5, 2008-01 ,pp. : 255-265

Karger

Access to resources Recommend Favorite